PDLIM7 and Epstein-Barr virus infection: During primary EBV infection, the lytic phase protein, gp350, and the latent phase protein, LMP1, jointly downregulate the TLR9 expression, a pattern recognition receptor that plays an important role in the immune response to the virus.